• 1. The reaction mechanism of sarcosine oxidase elucidated using FMO and QM/MM methods
  Yukihiro Abe,Mitsuo Shoji,Yoshiaki Nishiya,Hiroshi Aiba,Takahide Kishimoto,Kazuo Kitaura Phys. Chem. Chem. Phys. 2017 19 9811
• 2. A pharmaceutical cocrystal with potential anticancer activity
  Rajat Saha,Suman Sengupta,Sanjoy Kumar Dey,Ian M. Steele,Arindam Bhattacharyya,Susobhan Biswas,Sanjay Kumar RSC Adv. 2014 4 49070
• 3. Recognition and neutralization of angiotensins I and II using an artificial nanogel receptor fabricated by ligand specificity determinant imprinting
  Zerong Yu,Zhiguang Xu,He Li,Jianwen Chen,Zhiying Huang,Youwen Tang Chem. Commun. 2014 50 2728
• 4. Synthesis of polysarcosine from air and moisture stable N-phenoxycarbonyl-N-methylglycine assisted by tertiary amine base
  Afroditi Doriti,Sarah M. Brosnan,Steffen M. Weidner,Helmut Schlaad Polym. Chem. 2016 7 3067
• 5. Functionalization of the tetrairon cluster Cp4Fe4(CO)4 with fulleropyrrolidine
  Wen-Yann Yeh,Sung-Hua Wu Dalton Trans. 2013 42 12260

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Alpha amino acids
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Pharmaceutical and Biochemical Products Pharmaceutical Intermediates
• Pharmaceutical and Biochemical Products Pharmaceutical Active Ingredients

Introduction to Sarcosine (CAS No. 107-97-1): Applications and Recent Research Developments

Sarcosine, chemically known as N-methylglycine, is a non-proteinogenic amino acid with the molecular formula C?H?NO? and a CAS number of 107-97-1. This compound has garnered significant attention in the fields of biochemistry, pharmacology, and medicinal chemistry due to its unique structural and functional properties. Its simplicity as a zwitterionic molecule makes it an intriguing candidate for various biological applications, ranging from neurotransmitter modulation to potential therapeutic interventions.

The chemical structure of Sarcosine consists of an amino group, a carboxyl group, and a methyl group attached to the central carbon atom. This configuration imparts both basic and acidic characteristics, allowing it to participate in various biochemical interactions. Over the years, researchers have explored its role in numerous physiological processes, leading to a growing body of literature on its pharmacological significance.

In recent years, Sarcosine has been extensively studied for its potential in neurological disorders. Preclinical studies have demonstrated its ability to modulate neurotransmitter systems, particularly in relation to glutamate and GABA pathways. For instance, research indicates that Sarcosine may enhance GABA receptor activity, potentially offering therapeutic benefits in conditions such as epilepsy and anxiety disorders. These findings have spurred further investigation into its neuroprotective properties.

Moreover, Sarcosine has shown promise in the context of drug development. Its ability to act as a prodrug or a cofactor for certain enzymes has been explored in several clinical trials. Notably, studies have investigated its role in enhancing the bioavailability of other therapeutic agents by improving their metabolic stability or by facilitating their transport across biological membranes. This aspect of Sarcosine makes it a valuable component in formulations aimed at optimizing drug delivery systems.

Recent advancements in metabolomics have highlighted the importance of Sarcosine in cellular metabolism. Research suggests that Sarcosine levels can influence key metabolic pathways, including those involved in energy production and detoxification. This has opened up new avenues for studying its role in metabolic disorders such as diabetes and obesity. Additionally, the compound's interaction with gut microbiota has been implicated in modulating immune responses and gut health, further broadening its scope of applications.

The pharmaceutical industry has also been keen on exploring Sarcosine as a potential treatment for muscle-related disorders. Studies have shown that Sarcosine can help improve muscle function by inhibiting pathways that lead to muscle atrophy. This has led to clinical trials assessing its efficacy in conditions such as sarcopenia and muscular dystrophies. The results are promising, suggesting that Sarcosine could be a viable therapeutic option for patients suffering from these conditions.

Another area where Sarcosine has shown significant promise is in cancer research. Preliminary studies indicate that Sarcosine can modulate signaling pathways involved in tumor growth and metastasis. By interfering with key molecular targets such as EGFR and PI3K/Akt pathways, Sarcosine may offer a novel approach to cancer therapy. While more research is needed to fully understand its mechanisms of action, these findings are encouraging and warrant further exploration.

The industrial applications of Sarcosine are not limited to pharmaceuticals alone. Its use as a flavor enhancer and texturizer in food products has been well-documented. The compound's ability to improve the sensory qualities of foods without imparting any unwanted flavors or odors makes it an attractive option for food manufacturers seeking natural alternatives to synthetic additives.

In conclusion, Sarcosine (CAS No. 107-97-1) is a multifaceted compound with diverse applications across multiple scientific disciplines. Its role in neurological health, drug development, metabolic regulation, muscle function, and cancer research underscores its importance as a biochemical entity. As ongoing research continues to uncover new insights into its mechanisms of action and therapeutic potential, it is likely that the applications of Sarcosine will expand even further.

• 32607-00-4(Glycine,N-(carboxymethyl)-, sodium salt (1:1))
• 347840-04-4(Sarcosine-d3 Hydrochloride)
• 25951-24-0(Glycine, N-methyl-, homopolymer)
• 4316-73-8(Sarcosine Sodium Salt (40% in water))
• 142-73-4(Iminodiacetic acid)
• 637-96-7(2-(Methylamino)acetic acid hydrochloride)
• 118685-91-9(Sarcosine-d3)
• 207398-95-6(DisodiuM IMinodiacetate Hydrate)
• 68411-97-2(Cocoyl sarcosine)
• 61791-59-1(Glycine, N-methyl-,N-coco acyl derivs., sodium salts)